519 672 2121
Close mobile menu

Canada Newswire reports on Siskinds class action class action relating to the drug Neurontin®.To read full story, please visit http://www.newswire.ca/en/story/903975/canada-wide-neurontin-class-action-notice-of-certification.

News & Views

Blog

The more you understand, the easier it is to manage well.

View Blog

Tech company fundamentals – pre-incorporation IP

Entrepreneurs often develop intellectual property (IP), such as copyrightable source code, b…

The Canadian consumer: Regional differences and buying behaviour

A franchise system opens its first Canadian location in the Greater Toronto Area and perform…